{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:58:09Z","timestamp":1789095489907,"version":"build-2803163510"},"reference-count":192,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Growth hormone (GH)-secreting pituitary tumours represent the most genetically determined pituitary tumour type. This is true both for germline and somatic mutations. Germline mutations occur in several known genes (AIP, PRKAR1A, GPR101, GNAS, MEN1, CDKN1B, SDHx, MAX) as well as familial cases with currently unknown genes, while somatic mutations in GNAS are present in up to 40% of tumours. If the disease starts before the fusion of the epiphysis, then accelerated growth and increased final height, or gigantism, can develop, where a genetic background can be identified in half of the cases. Hereditary GH-secreting pituitary adenoma (PA) can manifest as isolated tumours, familial isolated pituitary adenoma (FIPA) including cases with AIP mutations or GPR101 duplications (X-linked acrogigantism, XLAG) or can be a part of systemic diseases like multiple endocrine neoplasia type 1 or type 4, McCune\u2013Albright syndrome, Carney complex or phaeochromocytoma\/paraganglioma-pituitary adenoma association. Family history and a search for associated syndromic manifestations can help to draw attention to genetic causes; many of these are now tested as part of gene panels. Identifying genetic mutations allows appropriate screening of associated comorbidities as well as finding affected family members before the clinical manifestation of the disease. This review focuses on germline and somatic mutations predisposing to acromegaly and gigantism.<\/jats:p>","DOI":"10.3390\/jcm10071377","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T16:01:57Z","timestamp":1617033717000},"page":"1377","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Genetics of Acromegaly and Gigantism"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-3924","authenticated-orcid":false,"given":"Anna","family":"Bogus\u0142awska","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-9432","authenticated-orcid":false,"given":"M\u00e1rta","family":"Korbonits","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.20945\/2359-3997000000193","article-title":"Determinants of morbidities and mortality in acromegaly","volume":"63","author":"Kasuki","year":"2019","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National acromegaly registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update","volume":"40","author":"Gadelha","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: Review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (pitnet): An international pituitary pathology club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11102-019-01027-w","article-title":"The tale in evolution: Clarity, consistency and consultation, not contradiction and confusion","volume":"23","author":"Ho","year":"2020","journal-title":"Pituitary"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11102-019-01015-0","article-title":"Pituitary neuroendocrine tumors (PitNETs): Nomenclature evolution, not clinical revolution","volume":"23","author":"Asa","year":"2020","journal-title":"Pituitary"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","article-title":"A tale of pituitary adenomas: To NET or not to NET: Pituitary Society position statement","volume":"22","author":"Ho","year":"2019","journal-title":"Pituitary"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ho, K., Fleseriu, M., Kaiser, U., Salvatori, R., Brue, T., Lopes, M.B., Kunz, P., Molitch, M., Camper, S.A., and Gadelha, M. (2021). Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?. J. Endocr. Soc.","DOI":"10.1210\/jendso\/bvaa205"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1210\/jcem-59-5-846","article-title":"Extrahypothalamic Growth-Hormone-Releasing Factor (GRF) Secretion Is a Rare Cause of Acromegaly: Plasma GRF Levels in 177 Acromegalic Patients","volume":"59","author":"Thorner","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/MEG.0b013e32835f433f","article-title":"Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype","volume":"25","author":"Sala","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11102-010-0226-7","article-title":"Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: Clinical experience following tumor resection and long-Acting octreotide therapy","volume":"15","author":"Butler","year":"2012","journal-title":"Pituitary"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ajmg.a.38308","article-title":"Growth hormone excess in children with neurofibromatosis type-1 and optic glioma","volume":"173","author":"Cambiaso","year":"2017","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/clinem\/dgz093","article-title":"IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction","volume":"105","author":"Joustra","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: An international collaborative study in 208 patients","volume":"22","author":"Rostomyan","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ghir.2016.09.007","article-title":"Gigantism: X-linked acrogigantism and GPR101 mutations","volume":"30\u201331","author":"Iacovazzo","year":"2016","journal-title":"Growth Horm. IGF Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers","volume":"100","author":"Gabrovska","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study","volume":"87","author":"Boureille","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2017-00372","article-title":"Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 study group","volume":"102","author":"Pieterman","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1210\/jc.2014-4297","article-title":"Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice","volume":"100","author":"Xekouki","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"D\u00e9nes, J., and Korbonits, M. (2021). The clinical aspects of pituitary tumour genetics. Endocrine.","DOI":"10.1007\/s12020-021-02633-0"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ecl.2020.05.005","article-title":"Update on the Genetics of Pituitary Tumors","volume":"49","author":"Barry","year":"2020","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.coemr.2018.04.002","article-title":"An update on the genetics of benign pituitary adenomas in children and adolescents","volume":"1","author":"Stratakis","year":"2018","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11102-017-0789-7","article-title":"The genetic background of acromegaly","volume":"20","author":"Gadelha","year":"2017","journal-title":"Pituitary"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ecl.2014.10.002","article-title":"Familial Isolated Pituitary Adenomas (FIPA) and Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene","volume":"44","author":"Daly","year":"2015","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1210\/clinem\/dgaa040","article-title":"Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors","volume":"105","author":"Marques","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: A cross-sectional study in the province of Li\u00e8ge, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11102-020-01085-5","article-title":"AIP variant causing familial prolactinoma","volume":"24","author":"Carty","year":"2020","journal-title":"Pituitary"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1210\/jc.2005-2671","article-title":"Clinical characterization of familial isolated pituitary adenomas","volume":"91","author":"Daly","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the Pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: An international collaborative study","volume":"95","author":"Daly","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.21292","article-title":"Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families","volume":"31","author":"Igreja","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2006-2513","article-title":"Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: Analysis in 73 families","volume":"92","author":"Daly","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2013-2868","article-title":"Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation","volume":"99","author":"Williams","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0079-6123(10)82010-2","article-title":"Molecular genetics of the aip gene in familial pituitary tumorigenesis","volume":"182","author":"Tahir","year":"2010","journal-title":"Prog. Brain Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kasuki, L., Neto, L.V., Wildemberg, L.E.A., Colli, L.M., de Castro, M., Takiya, C.M., and Gadelha, M.R. (2012). AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression. Endocr. Relat. Cancer.","DOI":"10.1530\/ERC-12-0020"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53","volume":"913","author":"Kasuki","year":"2011","journal-title":"Neuroendocrinology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1093\/nar\/24.23.4741","article-title":"XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation","volume":"24","author":"Kuzhandaivelu","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/BF03350345","article-title":"The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?","volume":"33","author":"Occhi","year":"2010","journal-title":"J. Endocrinol. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/EJE-17-0293","article-title":"In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism","volume":"177","author":"Salvatori","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1008020","article-title":"AIP mutation in pituitary adenomas in the 18th century and today","volume":"364","author":"Chahal","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/humu.23121","article-title":"Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland","volume":"38","author":"Radian","year":"2017","journal-title":"Hum. Mutat."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/JOE-11-0054","article-title":"AIP and its interacting partners","volume":"210","author":"Trivellin","year":"2011","journal-title":"J. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E1411","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: The role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tem.2012.11.007","article-title":"Novel pathway for somatostatin analogs in patients with acromegaly","volume":"24","author":"Gadelha","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/onc.2014.50","article-title":"AIP inactivation leads to pituitary tumorigenesis through defective G\u03b1i-cAMP signaling","volume":"34","author":"Tuominen","year":"2015","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.wneu.2018.11.021","article-title":"A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion","volume":"123","author":"Cai","year":"2019","journal-title":"World Neurosurg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/jmedgenet-2017-105191","article-title":"In vivo bioassay to test the pathogenicity of missense human AIP variants","volume":"55","author":"Aflorei","year":"2018","journal-title":"J. Med. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mce.2018.04.014","article-title":"Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas","volume":"476","author":"Bizzi","year":"2018","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1210\/jc.2019-00432","article-title":"Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation\u2012Positive Child","volume":"104","author":"Dutta","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.2012.04445.x","article-title":"Familial pituitary adenomas-Who should be tested for AIP mutations?","volume":"77","author":"Korbonits","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1530\/ERC-12-0322","article-title":"Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations","volume":"20","author":"Rotondi","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4158\/EP-2018-0500","article-title":"Predictive markers for postsurgical medical management of acromegaly: A systematic review and consensus treatment guideline","volume":"25","author":"Ezzat","year":"2019","journal-title":"Endocr. Pract."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/EC-19-0004","article-title":"Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients","volume":"8","author":"Daly","year":"2019","journal-title":"Endocr. Connect."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000375448","article-title":"Typical and atypical pituitary adenomas: A single-center analysis of outcome and prognosis","volume":"101","author":"Chiloiro","year":"2015","journal-title":"Neuroendocrinology"},{"key":"ref_61","first-page":"1","article-title":"Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas","volume":"10","author":"Kasuki","year":"2015","journal-title":"PLoS ONE"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/ijc.33268","article-title":"miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance","volume":"147","author":"Bogner","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04286.x","article-title":"Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly","volume":"77","author":"Heck","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2265.2011.04163.x","article-title":"Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly","volume":"76","author":"Fougner","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/ERC-15-0038","article-title":"X-linked acrogigantism syndrome: Clinical profile and therapeutic responses","volume":"22","author":"Beckers","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12020-015-0804-6","article-title":"Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome","volume":"51","author":"Naves","year":"2016","journal-title":"Endocrine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/ERC-15-0478","article-title":"GHRH excess and blockade in X-LAG syndrome","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","article-title":"Germline or somatic GPR101 duplication leads to X-linked acrogigantism: A clinico-pathological and genetic study","volume":"4","author":"Iacovazzo","year":"2016","journal-title":"Acta Neuropathol Commun."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Liang, H., Gong, F., Liu, Z., Yang, Y., Yao, Y., Wang, R., Wang, L., Chen, M., Pan, H., and Zhu, H. (2020). A Chinese case of X-linked acrogigantism and systemic review. Neuroendocrinology.","DOI":"10.1159\/000512240"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/ERC-16-0082","article-title":"Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11102-016-0743-0","article-title":"Childhood acromegaly due to X-linked acrogigantism: Long term follow-up","volume":"19","author":"Gordon","year":"2016","journal-title":"Pituitary"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2015-4366","article-title":"Somatic GPR101 duplication causing X-linked acrogigantism (XLAG)-Diagnosis and management","volume":"101","author":"Rodd","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1210\/jc.2019-00817","article-title":"Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother","volume":"104","author":"Zanazzi","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"E2078","DOI":"10.1210\/jc.2011-1401","article-title":"Hereditary pituitary hyperplasia with infantile gigantism","volume":"96","author":"Vortmeyer","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM199008023230507","article-title":"Gigantism due to pituitary mammosomatotroph hyperplasia","volume":"323","author":"Moran","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/ERC-11-0059","article-title":"Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation","volume":"18","author":"Villa","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"MEN1 2012 Guideline","volume":"97","author":"Thakker","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11102-019-00939-x","article-title":"Pituitary adenomas in patients with multiple endocrine neoplasia type 1: A single-center experience in China","volume":"22","author":"Wu","year":"2019","journal-title":"Pituitary"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2265.1997.3311122.x","article-title":"Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types","volume":"47","author":"Corbetta","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: Besides AIP don\u2019t forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/clinem\/dgaa142","article-title":"Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly","volume":"105","author":"Nachtigall","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jss.2011.03.014","article-title":"Parathyroidectomy in the elderly: Analysis of 7313 patients","volume":"170","author":"Thomas","year":"2011","journal-title":"J. Surg. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/er.2013-1071","article-title":"Growth hormone, insulin-like growth factor-1, and the kidney: Pathophysiological and clinical implications","volume":"35","author":"Mazziotti","year":"2014","journal-title":"Endocr. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Marques, P., Magalh\u00e3es, D., Caimari, F., Hern\u00e1ndez-Ram\u00edrez, L.C., Collier, D., Stals, K., Ellard, S., Drue, M., Akker, S., and Waterhouse, M. (2020). Phenotypic differences between patients with familial pituitary neuroendocrine tumours due to MEN1 or AIP mutations. Endocr. Abstr.","DOI":"10.1530\/endoabs.70.AEP600"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): A case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.2015.151","article-title":"Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas","volume":"29","author":"Mete","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ando.2012.09.004","article-title":"Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery","volume":"73","author":"Garby","year":"2012","journal-title":"Ann. Endocrinol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Isailovic, T., Todorovic, V., Milicevic, I., Petakov, M., Macut, D., Ognjanovic, S., Elezovic, V., Skender-Gazibara, M., popovic, B., and Antic, I.B. (2014). Ectopic co-secretion of growth hormone and growth hormone-releasing hormone from a neuroendocrine lung tumor in a patient with MEN1 syndrome. Endocr. Abstr.","DOI":"10.1530\/endoabs.35.P313"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Nadhamuni, V.S., Iacovazzo, D., Evanson, J., Trouillas, J., Kurzawinski, T., Bhattacharya, S., and Korbonits, M. (2019). Unusual cause of gigantism-Growth hormone releasing hormone (GHRH)-secreting pancreatic neuroendocrine tumour in a patient with multiple endocrine neoplasia type 1 (MEN1). Endocr. Abstr.","DOI":"10.1530\/endoabs.67.O36"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"24","author":"Thakker","year":"2010","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000495252","article-title":"Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients","volume":"86","author":"Yarman","year":"2019","journal-title":"Pathobiology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the Dutch MEN1 Study Group (DMSG)","volume":"100","author":"Dekkers","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): Analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"K15","DOI":"10.1530\/EJE-18-0778","article-title":"Germline and somatic mosaicism in a family with multiple endocrine neoplasia type 1 (MEN1) syndrome","volume":"180","author":"Beijers","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Mauchlen, R., Carty, D., Talla, M., and Drummond, R. (2019). Multiple endocrine neoplasia type 1 (MEN1) mosaicism caused by a c.124G>A variant in the MEN1 gene. Endocr. Abstr.","DOI":"10.1530\/endoabs.65.CC4"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J. Intern Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1073\/pnas.0503484102","article-title":"Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c","volume":"102","author":"Karnik","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1073\/pnas.0408836102","article-title":"Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors","volume":"102","author":"Milne","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2265.2002.01505.x","article-title":"Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions","volume":"56","author":"Cavaco","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"T161","DOI":"10.1530\/ERC-17-0249","article-title":"Animal models of MEN","volume":"24","author":"Mohr","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/ije.14.16","article-title":"Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies","volume":"1","author":"Agarwal","year":"2014","journal-title":"Int. J. Endocr. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1078-0432.CCR-07-1552","article-title":"Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type","volume":"14","author":"Korsisaari","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2265.2008.03379.x","article-title":"Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations","volume":"70","author":"Igreja","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Occhi, G., Regazzo, D., Trivellin, G., Boaretto, F., Citato, D., Bobisse, S., Ferasin, S., Cetani, F., Pardi, E., and Korbonits, M. (2013). A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype. PLoS Genet.","DOI":"10.1371\/journal.pgen.1003350"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-015-0540-y","article-title":"Early onset acromegaly associated with a novel deletion in CDKN1B 5\u2032UTR region","volume":"49","author":"Sambugaro","year":"2015","journal-title":"Endocrine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ando.2020.04.002","article-title":"Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies","volume":"81","author":"Chevalier","year":"2020","journal-title":"Ann. Endocrinol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","article-title":"Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing\u2019s Disease With or Without an MEN4 Phenotype","volume":"105","author":"Chasseloup","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare Germline Mutations in Cyclin-Dependent Kinase Inhibitor Genes in Multiple Endocrine Neoplasia Type 1 and Related States","volume":"94","author":"Agarwal","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Turner, J.J.O., Christie, P.T., Pearce, S.H.S., Turnpenny, P.D., and Thakker, R.V. (2010). Diagnostic challenges due to phenocopies: Lessons from Multiple Endocrine Neoplasia type1 (MEN1). Hum. Mutat.","DOI":"10.1002\/humu.21170"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-19-0522","article-title":"Whole genome sequencing of apparently mutation-negative MEN1 patients","volume":"182","author":"Backman","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2013-3826","article-title":"Acromegaly and mccune-albright syndrome","volume":"99","author":"Salenave","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Dumitrescu, C.E., and Collins, M.T. (2008). McCune-Albright syndrome. Orphanet J. Rare Dis.","DOI":"10.1186\/1750-1172-3-12"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0140-6736(91)91542-3","article-title":"Juvenile gigantism plus polyostotic fibrous dysplasia in the Tegernsee giant","volume":"338","author":"Nerlich","year":"1991","journal-title":"Lancet"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J. Neurooncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000182498","article-title":"G-protein oncogenes in acromegaly","volume":"117","author":"Spada","year":"1992","journal-title":"Horm. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory g protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_123","first-page":"750","article-title":"An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome","volume":"79","author":"Shenker","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1073\/pnas.89.11.5152","article-title":"Identification of a mutation in the gene encoding the \u03b1 subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome","volume":"89","author":"Schwindinger","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpeds.2018.09.070","article-title":"Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome","volume":"205","author":"Romanet","year":"2019","journal-title":"J. Pediatr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/cen.13419","article-title":"Long-term health outcomes of adults with McCune-Albright syndrome","volume":"87","author":"Wong","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2032-monophosphate-dependent protein kinase (PRKAR1A): Phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11102-019-00974-8","article-title":"Acromegaly in Carney complex","volume":"22","author":"Cuny","year":"2019","journal-title":"Pituitary"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: An update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CCO.0b013e32801195eb","article-title":"Carney complex: The first 20 years","volume":"19","author":"Boikos","year":"2007","journal-title":"Curr. Opin. Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/js.2017-00283","article-title":"Harvey Cushing Treated the First Known Patient With Carney Complex","volume":"1","author":"Tsay","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000345669","article-title":"Carney complex","volume":"41","author":"Espiard","year":"2013","journal-title":"Front. Horm. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/en.2004-0900","article-title":"Minireview: PRKAR1A: Normal and abnormal functions","volume":"145","author":"Bossis","year":"2004","journal-title":"Endocrinology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1210\/jc.2013-3159","article-title":"Deletions of the PRKAR1A locus at 17q24.2\u2013q24.3 in Carney complex: Genotype-phenotype correlations and implications for genetic testing","volume":"99","author":"Salpea","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMc1309730","article-title":"PRKACB and Carney complex","volume":"370","author":"Forlino","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_137","unstructured":"Forlino, A., Vetro, A., Garavelli, L., Ciccone, R., London, E., Stratakis, C.A., and Zuffardi, O. (2014). Genetic Diagnosis in Whole Genome Sequencing. N. Engl. J. Med., 1067\u20131069."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1210\/jc.2017-01045","article-title":"Fatal carney complex in siblings due to de novo large gene deletion","volume":"102","author":"Tutka","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2007-0797","article-title":"Genetics of carney triad: Recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors","volume":"92","author":"Matyakhina","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI118467","article-title":"Carney complex, a familial multiple neoplasia and lentiginosis syndrome: Analysis of 11 kindreds and linkage to the short arm of chromosome","volume":"97","author":"Stratakis","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0954-6820.1952.tb13837.x","article-title":"Acromegaly Associated with Ph\u00e6ochromocytoma","volume":"142","author":"Ivesen","year":"1952","journal-title":"Acta Med. Scand."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: A retrospective and prospective analysis","volume":"10","author":"Gaal","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Xekouki, P., Pacak, K., Almeida, M., Wassif, C.A., Rustin, P., Nesterova, M., de la Luz Sierra, M., Matro, J., Ball, E., and Azevedo, M. (2012). Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: A new association for SDH?. J. Clin. Endocrinol. Metab.","DOI":"10.1210\/jc.2011-1179"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1530\/ERC-15-0241","article-title":"The association of pituitary adenomas and phaeochromocytomas or paragangliomas","volume":"22","author":"Robledo","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/EJE-20-0054","article-title":"Germinal defects of SDHx genes in patients with isolated pituitary adenoma","volume":"183","author":"Mougel","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/a-0661-0341","article-title":"The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors","volume":"51","author":"Xekouki","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: Results from a large patient cohort","volume":"100","author":"Swords","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-\u03b1 prolyl hydroxylase","volume":"7","author":"Selak","year":"2015","journal-title":"Cancer Cell."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1530\/ERC-18-0065","article-title":"Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions","volume":"25","author":"Daly","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral Pheochromocytomas","volume":"1","author":"Roszko","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/2159-8290.CD-13-0799","article-title":"MAX inactivation in small cell lung cancer disrupts MYC-SWI\/SNF programs and is synthetic lethal with BRG","volume":"4","author":"Romero","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11684-018-0650-z","article-title":"The MYC transcription factor network: Balancing metabolism, proliferation and oncogenesis","volume":"12","author":"Carroll","year":"2018","journal-title":"Front. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Schiavi","year":"2011","journal-title":"Nat. Gen."},{"key":"ref_155","first-page":"20-0119","article-title":"Identification of a TMEM127 variant in a patient with paraganglioma and acromegaly","volume":"2020","author":"Korbonits","year":"2020","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2019.08.005","article-title":"3P association (3PAs): Pituitary adenoma and pheochromocytoma\/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations","volume":"69","author":"Fajardo","year":"2019","journal-title":"Eur. J. Intern Med."},{"key":"ref_157","first-page":"46","article-title":"Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma","volume":"18","author":"Taboada","year":"2017","journal-title":"Endocr. Pathol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12020-012-9790-0","article-title":"Ectopic acromegaly due to growth hormone releasing hormone","volume":"43","author":"Ghazi","year":"2013","journal-title":"Endocrine"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Seabrook, A.J., Harris, J.E., Velosa, S.B., Kim, E., McInerney-Leo, A.M., Dwight, T., Hockings, J.I., Hockings, N.G., Kirk, J., and Leo, P.J. (2020). Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?. J. Clin. Endocrinol. Metab.","DOI":"10.1210\/clinem\/dgaa957"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000447326","article-title":"Growth Hormone Excess in Children with Optic Pathway Tumors Is a Transient Phenomenon","volume":"86","author":"Josefson","year":"2016","journal-title":"Horm. Res. Paediatr."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000369802","article-title":"Endocrine implications of neurofibromatosis 1 in childhood","volume":"83","author":"Bizzarri","year":"2015","journal-title":"Horm. Res. Paediatr."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41436-018-0312-1","article-title":"Growth hormone excess in neurofibromatosis","volume":"21","author":"Stratakis","year":"2019","journal-title":"Genet. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1507\/endocrj.EJ19-0035","article-title":"Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type","volume":"66","author":"Hozumi","year":"2019","journal-title":"Endocr. J."},{"key":"ref_164","first-page":"144","article-title":"Acromegaly and type 1 neurofibromatosis. Is association of both conditions due to chance?","volume":"60","year":"2013","journal-title":"Endocrinol. Nutr."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1474-4422(14)70255-8","article-title":"A multidisciplinary approach in neurofibromatosis","volume":"14","author":"Milani","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/ERC-14-0465","article-title":"Is IGSF1 involved in human pituitary tumor formation?","volume":"22","author":"Faucz","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(78)81170-6","article-title":"Acromegalic gigantism and tuberous sclerosis","volume":"93","author":"Hoffman","year":"1978","journal-title":"J. Pediatr."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2005.02374.x","article-title":"Simultaneous Cushing\u2019s disease and tuberous sclerosis; a potential role for TSC in pituitary ontogeny","volume":"63","author":"Tigas","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.2007.02941.x","article-title":"Cushing\u2019s syndrome due to a pituitary corticotropinoma in a child with tuberous sclerosis: An association or a coincidence?","volume":"67","author":"Nandagopal","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_171","first-page":"1","article-title":"Silent gonadotroph pituitary neuroendocrine tumor in a patient with tuberous sclerosis complex: Evaluation of a possible molecular link","volume":"2018","author":"Regazzo","year":"2018","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic Classification of Pituitary Neuroendocrine Tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/cr.2016.114","article-title":"The genome-wide mutational landscape of pituitary adenomas","volume":"26","author":"Song","year":"2016","journal-title":"Cell Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the \u03b1 chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1507\/endocrj.EJ16-0075","article-title":"Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma","volume":"63","author":"Matsumoto","year":"2016","journal-title":"Endocr. J."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-10-0586","article-title":"Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae","volume":"163","author":"Bakhtiar","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/EJE-13-0134","article-title":"Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas","volume":"169","author":"Mayr","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Hayward, B.E., Barlier, A., Korbonits, M., Grossman, A.B., Jacquet, P., Enjalbert, A., and Bonthron, D.T. (2001). Imprinting of the Gs\u03b1 gene GNAS1 in the pathogenesis of acromegaly. J. Clin. Investig.","DOI":"10.1172\/JCI11887"},{"key":"ref_179","first-page":"111","article-title":"Genetics of Pituitary Adenomas","volume":"41","author":"Gadelha","year":"2013","journal-title":"Endocr. Tumor Syndr. Genet. Front Horm. Res. Basel. Karger."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/EJE-16-0831","article-title":"The GIP\/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp-somatotropinomas","volume":"176","author":"Regazzo","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1210\/jc.2018-01360","article-title":"Paradoxical GH Increase during OGTT Is Associated with First-Generation Somatostatin Analog Responsiveness in Acromegaly","volume":"104","author":"Scaroni","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/mend-1-2-137","article-title":"Differential activation of type I and type II 3\u2032,5\u2032-cyclic adenosine monophosphate-dependent protein kinases by growth hormone releasing factor","volume":"1","author":"Bilezikjian","year":"1987","journal-title":"Mol. Endocrinol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10059-010-0100-5","article-title":"Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors","volume":"30","author":"Moon","year":"2010","journal-title":"Mol. Cells"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1210\/jc.2018-01504","article-title":"Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas","volume":"104","author":"Hage","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-19-0139","article-title":"Determinants of the growth hormone nadir during oral glucose tolerance test in adults","volume":"181","author":"Schilbach","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-15-1064","article-title":"Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas","volume":"174","author":"Ronchi","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1210\/jc.2015-3129","article-title":"Whole-genome sequencing of growth hormone (GH)-secreting pituitary adenomas","volume":"100","author":"Demir","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/clinem\/dgaa857","article-title":"Clinical Outcomes and Complications of Pituitary Blastoma","volume":"106","author":"Liu","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_189","unstructured":"Nadhamuni, V.S., and Korbonits, M. (2020). Novel insights into pituitary tumorigenesis: Genetic and epigenetic mechanisms. Endocr. Rev."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.1016\/j.yfrne.2020.100852","article-title":"The Tumour Microenvironment of Pituitary Neuroendocrine Tumours","volume":"58","author":"Marques","year":"2020","journal-title":"Front. Neuroendocrinol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/ERC-19-0327","article-title":"Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness","volume":"26","author":"Marques","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/jmedgenet-2017-104957","article-title":"International FIPA consortium. Risk category system to identify pituitary adenoma patients with AIP mutations","volume":"55","author":"Caimari","year":"2018","journal-title":"J. Med. Genet."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/7\/1377\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:33:10Z","timestamp":1760362390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/7\/1377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":192,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["jcm10071377"],"URL":"https:\/\/doi.org\/10.3390\/jcm10071377","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]}}}